ecrin-mdr-crcClinical2018Colorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2274289United States6Metastatic Colorectal CancerCabozantinibTumorProgression Free SurvivalECRIN MDRCompletedfalseInvestigating Cabozantinib in Patients With Refractory Metastatic Colorectal CancerThis study seeks to use Cabozantinib to treat those with Metastatic Colorectal Cancer who have not previously responded to treatment.2018-06-152274289NCT03542877